Loading...
BTH0 logo

BIOLASE, Inc.DB:BTH0 Stock Report

Market Cap €2.8m
Share Price
n/a
€0.39
n/aintrinsic discount
1Y-99.9%
7D0%
Portfolio Value
View

BIOLASE, Inc.

DB:BTH0 Stock Report

Market Cap: €2.8m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

BIOLASE (BTH0) Stock Overview

Develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. More details

BTH0 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health2/6
Dividends0/6

BTH0 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

BIOLASE, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BIOLASE
Historical stock prices
Current Share PriceUS$0.01
52 Week HighUS$9.00
52 Week LowUS$0.01
Beta0.72
1 Month Change-91.97%
3 Month Change-89.90%
1 Year Change-99.86%
3 Year Change-100.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

BTH0DE Medical EquipmentDE Market
7D0%4.8%2.5%
1Y-99.9%-16.9%8.8%

Return vs Industry: BTH0 underperformed the German Medical Equipment industry which returned 1% over the past year.

Return vs Market: BTH0 underperformed the German Market which returned 3.3% over the past year.

Price Volatility

Is BTH0's price volatile compared to industry and market?
BTH0 volatility
BTH0 Average Weekly Movement37.2%
Medical Equipment Industry Average Movement5.5%
Market Average Movement6.0%
10% most volatile stocks in DE Market13.8%
10% least volatile stocks in DE Market2.7%

Stable Share Price: BTH0's share price has been volatile over the past 3 months.

Volatility Over Time: BTH0's weekly volatility (37%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
1984157John Beaverwww.biolase.com

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production.

BIOLASE, Inc. Fundamentals Summary

How do BIOLASE's earnings and revenue compare to its market cap?
BTH0 fundamental statistics
Market cap€2.77m
Earnings (TTM)-€35.36m
Revenue (TTM)€45.13m
0.1x
P/S Ratio
-0.1x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BTH0 income statement (TTM)
RevenueUS$48.83m
Cost of RevenueUS$32.11m
Gross ProfitUS$16.72m
Other ExpensesUS$54.98m
Earnings-US$38.25m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.15
Gross Margin34.25%
Net Profit Margin-78.35%
Debt/Equity Ratio5,207.1%

How did BTH0 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/10 18:04
End of Day Share Price 2024/07/04 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BIOLASE, Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Bruce JacksonBenchmark Company
Kyle BauserColliers Securities